BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9855569)

  • 1. Perillyl alcohol: applications in oncology.
    Belanger JT
    Altern Med Rev; 1998 Dec; 3(6):448-57. PubMed ID: 9855569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumorigenic effects of limonene and perillyl alcohol against pancreatic and breast cancer.
    Crowell PL; Siar Ayoubi A; Burke YD
    Adv Exp Med Biol; 1996; 401():131-6. PubMed ID: 8886131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy of pancreatic cancer with the monoterpene perillyl alcohol.
    Stark MJ; Burke YD; McKinzie JH; Ayoubi AS; Crowell PL
    Cancer Lett; 1995 Sep; 96(1):15-21. PubMed ID: 7553603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of monoterpenes and mevinolin on murine colon tumor CT-26 in vitro and its hepatic "metastases" in vivo.
    Broitman SA; Wilkinson J; Cerda S; Branch SK
    Adv Exp Med Biol; 1996; 401():111-30. PubMed ID: 8886130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention and therapy of cancer by dietary monoterpenes.
    Crowell PL
    J Nutr; 1999 Mar; 129(3):775S-778S. PubMed ID: 10082788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the transforming growth factor beta signaling pathway and induction of cytostasis and apoptosis in mammary carcinomas treated with the anticancer agent perillyl alcohol.
    Ariazi EA; Satomi Y; Ellis MJ; Haag JD; Shi W; Sattler CA; Gould MN
    Cancer Res; 1999 Apr; 59(8):1917-28. PubMed ID: 10213501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the antitumor agent perillyl alcohol on H-Ras vs. K-Ras farnesylation and signal transduction in pancreatic cells.
    Stayrook KR; McKinzie JH; Barbhaiya LH; Crowell PL
    Anticancer Res; 1998; 18(2A):823-8. PubMed ID: 9615726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II trial of daily perillyl alcohol in patients with advanced ovarian cancer: Eastern Cooperative Oncology Group Study E2E96.
    Bailey HH; Levy D; Harris LS; Schink JC; Foss F; Beatty P; Wadler S
    Gynecol Oncol; 2002 Jun; 85(3):464-8. PubMed ID: 12051875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I study of perillyl alcohol in patients with refractory malignancies.
    Murren JR; Pizzorno G; DiStasio SA; McKeon A; Peccerillo K; Gollerkari A; McMurray W; Burtness BA; Rutherford T; Li X; Ho PT; Sartorelli A
    Cancer Biol Ther; 2002; 1(2):130-5. PubMed ID: 12170772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I trial of perillyl alcohol in patients with advanced solid tumors.
    Azzoli CG; Miller VA; Ng KK; Krug LM; Spriggs DR; Tong WP; Riedel ER; Kris MG
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):493-8. PubMed ID: 12695855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer chemoprevention and therapy by monoterpenes.
    Gould MN
    Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):977-9. PubMed ID: 9255590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of apoptosis in liver tumors by the monoterpene perillyl alcohol.
    Mills JJ; Chari RS; Boyer IJ; Gould MN; Jirtle RL
    Cancer Res; 1995 Mar; 55(5):979-83. PubMed ID: 7867007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I clinical trial of perillyl alcohol administered daily.
    Ripple GH; Gould MN; Stewart JA; Tutsch KD; Arzoomanian RZ; Alberti D; Feierabend C; Pomplun M; Wilding G; Bailey HH
    Clin Cancer Res; 1998 May; 4(5):1159-64. PubMed ID: 9607573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention and therapy of mammary cancer by monoterpenes.
    Gould MN
    J Cell Biochem Suppl; 1995; 22():139-44. PubMed ID: 8538191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of ubiquinone and cholesterol synthesis by the monoterpene perillyl alcohol.
    Ren Z; Gould MN
    Cancer Lett; 1994 Jan; 76(2-3):185-90. PubMed ID: 8149348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of active drug metabolites after oral administration of perillyl alcohol, an investigational antineoplastic agent, to the dog.
    Phillips LR; Malspeis L; Supko JG
    Drug Metab Dispos; 1995 Jul; 23(7):676-80. PubMed ID: 7587953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of the apoptosis-promoting protein Bak by perillyl alcohol in pancreatic ductal adenocarcinoma relative to untransformed ductal epithelial cells.
    Stayrook KR; McKinzie JH; Burke YD; Burke YA; Crowell PL
    Carcinogenesis; 1997 Aug; 18(8):1655-8. PubMed ID: 9276644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of differentiation in neuro-2A cells by the monoterpene perillyl alcohol.
    Shi W; Gould MN
    Cancer Lett; 1995 Aug; 95(1-2):1-6. PubMed ID: 7656215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoprevention of colon carcinogenesis by dietary perillyl alcohol.
    Reddy BS; Wang CX; Samaha H; Lubet R; Steele VE; Kelloff GJ; Rao CV
    Cancer Res; 1997 Feb; 57(3):420-5. PubMed ID: 9012468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study of perillyl alcohol in pancreatic cancer.
    Matos JM; Schmidt CM; Thomas HJ; Cummings OW; Wiebke EA; Madura JA; Patrick LJ; Crowell PL
    J Surg Res; 2008 Jun; 147(2):194-9. PubMed ID: 18498869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.